Table 3.
Organ involvement among different age-onset groups.
| Organ involvement on admission |
All (n = 797) |
JSLEa (n = 88) |
ASLEb (n = 638) |
LSLEc (n = 71) |
P |
|---|---|---|---|---|---|
| Mucocutaneous (%) | 582 (73.0) | 70 (79.5) | 468 (73.4) | 44 (62.0) | 0.042 |
| Neuropsychiatric (%) | 52 (6.5) | 5 (5.7) | 44 (6.9) | 3 (4.2) | 0.650 |
| Musculoskeletal (%) | 488 (61.2) | 53 (60.2) | 388 (60.8) | 47 (66.2) | 0.663 |
| Cardiopulmonary (%) | 186 (23.3) | 10 (11.4) | 155 (24.3) | 21 (29.6) | 0.012 |
| Gastrointestinal (%) | 169 (21.2) | 23 (26.1) | 134 (21.0) | 12 (16.9) | 0.353 |
| Ophthalmologic (%) | 7 (0.9) | 0 (0.0) | 6 (0.9) | 1 (1.4) | 0.595 |
| Renal (%) | 450 (56.5) | 52 (59.1) | 363 (56.9) | 35 (49.3) | 0.411 |
| Hematologic (%) | 388 (48.7) | 39 (44.3) | 310 (48.6) | 39 (54.9) | 0.410 |
aJSLE juvenile-onset SLE; bASLE adult-onset SLE; cLSLE late-onset SLE.